The first and most significant money for innovative biotech in China
TF Capital
First & Foremost Investor
Partnering with early-stage innovators from the start
Full Value-Chain Support
Providing comprehensive capital and strategic expertise
Impactful Investment
$1B
AUM
100+
Portfolios
20
IPOs
Our Value Creation:
From Proprietary Sourcing to High-Value Realization
High-Quality Sourcing
in-depth biopharmaceutical industrial networks and exclusive founder relationships
Diverse Partnernships
listed companies, leading clinical experts, renowned investment funds
$2.8B+ in Upfronts License-Out
generated from 25 deals across 14 companies in 5 consecutive years with MNCs
Out-standing Exit Performance
20 IPOs and 15+ portfolio companies are in IPO filing